Radnostix revenue falls 27% amid product recalls and FDA actions
Tweet Send to a Friend
Radnostix, Inc. (OTCQB: INIS), formerly International Isotopes Inc., reported a 27% decline in revenue for the second quarter ended June ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




